Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair

Journal of Clinical Investigation

Volumn 123, Issue 1, 2013, Pages 443-454

  Leoni, Giovanna ^a   Alam, Ashfaqul ^a   Alexander Neumann, Philipp ^a,b   Lambeth, J David ^a   Cheng, Guangjie ^c   McCoy, James ^a   Hilgarth, Roland S ^a   Kundu, Kousik ^d   Murthy, Niren ^d   Kusters, Dennis ^e   Reutelingsperger, Chris ^e   Perretti, Mauro ^f   Parkos, Charles A ^a   Neish, Andrew S ^a   Nusrat, Asma ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c Allergy and Critical Care Medicine   (United States)

^d GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^e MAASTRICHT UNIVERSITY   (Netherlands)

^f QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FOCAL ADHESION KINASE; FORMYLPEPTIDE RECEPTOR; LIPOCORTIN 1; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 12; PAXILLIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE; RECOMBINANT PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1;

AEROBIC METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL INFILTRATION; CELL MIGRATION; COLITIS; COLONOSCOPY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INACTIVATION; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; INTESTINE EPITHELIUM; INTESTINE MUCOSA; LEUKOCYTE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ULCERATIVE COLITIS; WOUND HEALING;

ANIMALS; ANNEXIN A1; CELL LINE; COLITIS, ULCERATIVE; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTESTINAL MUCOSA; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NADH, NADPH OXIDOREDUCTASES; NADPH OXIDASE; PEPTIDES; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 12; PTEN PHOSPHOHYDROLASE; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 84873816901     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI65831     Document Type: Article

References (92)

1. Lotz MM, Nusrat A, Madara JL, Ezzell R, Wewer UM, Mercurio AM. Intestinal epithelial restitution. Involvement of specific laminin isoforms and integrin laminin receptors in wound closure of a transformed model epithelium. Am J Pathol. 1997;150(2): 747-760.
2. Perretti M, et al. Endogenous lipid- and peptidederived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat Med. 2002;8(11): 1296-1302.
3. Serhan CN. The resolution of inflammation: the devil in the flask and in the details. FASEB J. 2011;25(5): 1441-1448.
4. Serhan CN. Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators. J Thromb Haemost. 2009;7(suppl 1): 44-48.
5. Serhan CN, et al. Resolution of inflammation: state of the art, definitions and terms. FASEB J. 2007;21(2): 325-332.
6. Norling LV, Spite M, Yang R, Flower RJ, Perretti M, Serhan CN. Cutting edge: humanized nanoproresolving medicines mimic inflammationresolution and enhance wound healing. J Immunol. 2011;186(10): 5543-5547.
7. Serhan CN, Levy B. Novel pathways and endogenous mediators in anti-inflammation and resolution. Chem Immunol Allergy. 2003;83: 115-145.
8. Levy BD, et al. Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4). Nat Med. 2002;8(9): 1018-1023.
9. Perretti M, D'Acquisto F. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat Rev Immunol. 2009;9(1): 62-70.
10. Yang YH, et al. Modulation of inflammation and response to dexamethasone by Annexin 1 in antigen-induced arthritis. Arthritis Rheum. 2004;50(3): 976-984.
11. Damazo AS, Yona S, Flower RJ, Perretti M, Oliani SM. Spatial and temporal profiles for antiinflammatory gene expression in leukocytes during a resolving model of peritonitis. J Immunol. 2006;176(7): 4410-4418.
12. Damazo AS, Yona S, D'Acquisto F, Flower RJ, Oliani SM, Perretti M. Critical protective role for annexin 1 gene expression in the endotoxemic murine microcirculation. Am J Pathol. 2005;166(6): 1607-1617.
13. Perretti M. Lipocortin 1 and chemokine modulation of granulocyte and monocyte accumulation in experimental inflammation. Gen Pharmacol. 1998;31(4): 545-552.
14. La M, et al. Annexin 1 peptides protect against experimental myocardial ischemia-reperfusion: analysis of their mechanism of action. FASEB J. 2001;15(12): 2247-2256.
15. Liu L, Zimmerman UJ. An intramolecular disulfide bond is essential for annexin I-mediated liposome aggregation. Biochem Mol Biol Int. 1995;35(2): 345-350.
16. Oliani SM, Paul-Clark MJ, Christian HC, Flower RJ, Perretti M. Neutrophil interaction with inflamed postcapillary venule endothelium alters annexin 1 expression. Am J Pathol. 2001;158(2): 603-615.
17. Perretti M. The annexin 1 receptor(s): is the plot unravelling? Trends Pharmacol Sci. 2003;24(11): 574-579.
18. Walther A, Riehemann K, Gerke V. A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR. Mol Cell. 2000;5(5): 831-840.
19. Ye RD, et al. International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev. 2009;61(2): 119-161.
20. Le Y, Murphy PM, Wang JM. Formyl-peptide receptors revisited. Trends Immunol. 2002;23(11): 541-548.
21. Bylund J, Samuelsson M, Collins LV, Karlsson A. NADPH-oxidase activation in murine neutrophils via formyl peptide receptors. Exp Cell Res. 2003;282(2): 70-77.
22. Hurd TR, DeGennaro M, Lehmann R. Redox regulation of cell migration and adhesion. Trends Cell Biol. 2012;22(2): 107-115.
23. Babbin BA, et al. Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors. J Biol Chem. 2006;281(28): 19588-19599.
24. Ernst S, Lange C, Wilbers A, Goebeler V, Gerke V, Rescher U. An annexin 1 N-terminal peptide activates leukocytes by triggering different members of the formyl peptide receptor family. J Immunol. 2004;172(12): 7669-7676.
25. Hayhoe RP, Kamal AM, Solito E, Flower RJ, Cooper D, Perretti M. Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement. Blood. 2006;107(5): 2123-2130.
26. Wenzel-Seifert K, Seifert R. Cyclosporin H is a potent and selective formyl peptide receptor antagonist. Comparison with N-t-butoxycarbonyl- L-phenylalanyl-L-leucyl-L-phenylalanyl-L- leucyl- L-phenylalanine and cyclosporins A, B, C, D, and E. J Immunol. 1993;150(10): 4591-4599.
27. Stenfeldt AL, Karlsson J, Wenneras C, Bylund J, Fu H, Dahlgren C. Cyclosporin H, Boc-MLF and Boc- FLFLF are antagonists that preferentially inhibit activity triggered through the formyl peptide receptor. Inflammation. 2007;30(6): 224-229.
28. Bae YS, et al. Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling. J Immunol. 2004;173(1): 607-614.
29. Hu JY, et al. Synthetic peptide MMK-1 is a highly specific chemotactic agonist for leukocyte FPRL1. J Leukoc Biol. 2001;70(1): 155-161.
30. Migeotte I, et al. Identification and characterization of an endogenous chemotactic ligand specific for FPRL2. J Exp Med. 2005;201(1): 83-93.
31. Devosse T, et al. Processing of HEBP1 by cathepsin D gives rise to F2L, the agonist of formyl peptide receptor 3. J Immunol. 2011;187(3): 1475-1485.
32. Ridley AJ, et al. Cell migration: integrating signals from front to back. Science. 2003; 302(5651): 1704-1709.
33. Sieg DJ, Hauck CR, Schlaepfer DD. Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. J Cell Sci. 1999;16(pt 16): 2677-2691.
34. Swanson PA 2nd, et al. Enteric commensal bacteria potentiate epithelial restitution via reactive oxygen species-mediated inactivation of focal adhesion kinase phosphatases. Proc Natl Acad Sci U S A. 2011;108(21): 8803-8808.
35. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol. 2004;4(3): 181-189.
36. Smigel M, Katada T, Northup JK, Bokoch GM, Ui M, Gilman AG. Mechanisms of guanine nucleotide- mediated regulation of adenylate cyclase activity. Adv Cyclic Nucleotide Protein Phosphorylation Res. 1984;17: 1-18.
37. Jones DP. Radical-free biology of oxidative stress. Am J Physiol Cell Physiol. 2008;295(4):C849-868.
38. Rhee SG, Chang TS, Bae YS, Lee SR, Kang SW. Cellular regulation by hydrogen peroxide. J Am Soc Nephrol. 2003;14(8 suppl 3):S211-S215.
39. Terada LS. Specificity in reactive oxidant signaling: think globally, act locally. J Cell Biol. 2006;174(5): 615-623.
40. Boivin B, Yang M, Tonks NK. Targeting the reversibly oxidized protein tyrosine phosphatase superfamily. Sci Signal. 2010;3(137):pl2.
41. Angers-Loustau A, Cote JF, Tremblay ML. Roles of protein tyrosine phosphatases in cell migration and adhesion. Biochem Cell Biol. 1999;77(6): 493-505.
42. Wade R, Brimer N, Lyons C, Vande Pol S. Paxillin enables attachment-independent tyrosine phosphorylation of focal adhesion kinase and transformation by RAS. J Biol Chem. 2011;286(44): 37932-37944.
43. Zheng Y, Yang W, Xia Y, Hawke D, Liu DX, Lu Z. Ras-induced and extracellular signal-regulated kinase 1 and 2 phosphorylation-dependent isomerization of protein tyrosine phosphatase (PTP)- PEST by PIN1 promotes FAK dephosphorylation by PTP-PEST. Mol Cell Biol. 2011;31(21): 4258-4269.
44. Bagrodia S, Taylor SJ, Creasy CL, Chernoff J, Cerione RA. Identification of a mouse p21Cdc42/Rac activated kinase. J Biol Chem. 1995;270(39): 22731-22737.
45. Bagrodia S, Taylor SJ, Jordon KA, Van Aelst L, Cerione RA. A novel regulator of p21-activated kinases. J Biol Chem. 1998;273(37): 23633-23636.
46. Takai Y, Sasaki T, Matozaki T. Small GTP-binding proteins. Physiol Rev. 2001;81(1): 153-208.
47. Noren NK, Liu BP, Burridge K, Kreft B. p120 catenin regulates the actin cytoskeleton via Rho family GTPases. J Cell Biol. 2000;150(3): 567-580.
48. Cheng G, Diebold BA, Hughes Y, Lambeth JD. Nox1- dependent reactive oxygen generation is regulated by Rac1. J Biol Chem. 2006;281(26): 17718-17726.
49. Gao Y, Dickerson JB, Guo F, Zheng J, Zheng Y. Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc Natl Acad Sci U S A. 2004;101(20): 7618-7623.
50. Reynolds AB, Daniel J, McCrea PD, Wheelock MJ, Wu J, Zhang Z. Identification of a new catenin: the tyrosine kinase substrate p120cas associates with E-cadherin complexes. Mol Cell Biol. 1994;14(12): 8333-8342.
51. Gianni D, Taulet N, DerMardirossian C, Bokoch GM. c-Src-mediated phosphorylation of NoxA1 and Tks4 induces the reactive oxygen species (ROS)-dependent formation of functional invadopodia in human colon cancer cells. Mol Biol Cell. 2010;21(23): 4287-4298.
52. Xu KP, Yin J, Yu FS. SRC-family tyrosine kinases in wound- and ligand-induced epidermal growth factor receptor activation in human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2006;47(7): 2832-2839.
53. Yezhelyev MV, et al. Inhibition of SRC tyrosine kinase as treatment for human pancreatic cancer growing orthotopically in nude mice. Clin Cancer Res. 2004;10(23): 8028-8036.
54. Nam JS, Ino Y, Sakamoto M, Hirohashi S. Src family kinase inhibitor PP2 restores the E-cadherin/catenin cell adhesion system in human cancer cells and reduces cancer metastasis. Clin Cancer Res. 2002;8(7): 2430-2436.
55. Hanke JH, et al. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J Biol Chem. 1996;271(2): 695-701.
56. Vong L, et al. Up-regulation of Annexin-A1 and lipoxin A(4) in individuals with ulcerative colitis may promote mucosal homeostasis. PLoS One. 2012;7(6):e39244.
57. Morise Z, Grisham MB. Molecular mechanisms involved in NSAID-induced gastropathy. J Clin Gastroenterol. 1998;27(suppl 1):S87-S90.
58. Kosone T, et al. Integrative roles of transforming growth factor-alpha in the cytoprotection mechanisms of gastric mucosal injury. BMC Gastroenterol. 2006;6:22.
59. Ouyang N, et al. MC-12, an annexin A1-based peptide, is effective in the treatment of experimental colitis. PLoS One. 2012;7(7):e41585.
60. Babbin BA, et al. Annexin A1 regulates intestinal mucosal injury, inflammation, and repair. J Immunol. 2008;181(7): 5035-5044.
61. Martin GR, Perretti M, Flower RJ, Wallace JL. Annexin-1 modulates repair of gastric mucosal injury. Am J Physiol Gastrointest Liver Physiol. 2008;294(3):G764-G769.
62. Brancaleone V, Dalli J, Bena S, Flower RJ, Cirino G, Perretti M. Evidence for an anti-inflammatory loop centered on polymorphonuclear leukocyte formyl peptide receptor 2/lipoxin A4 receptor and operative in the inflamed microvasculature. J Immunol. 2011;186(8): 4905-4914.
63. Dalli J, Jones CP, Cavalcanti DM, Farsky SH, Perretti M, Rankin SM. Annexin A1 regulates neutrophil clearance by macrophages in the mouse bone marrow. FASEB J. 2012;26(1): 387-396.
64. Dalli J, Montero-Melendez T, McArthur S, Perretti M. Annexin A1 N-terminal derived Peptide ac2-26 exerts chemokinetic effects on human neutrophils. Front Pharmacol. 2012;3:28.
65. Lim LH, Solito E, Russo-Marie F, Flower RJ, Perretti M. Promoting detachment of neutrophils adherent to murine postcapillary venules to control inflammation: effect of lipocortin 1. Proc Natl Acad Sci U S A. 1998;95(24): 14535-14539.
66. John C, et al. Annexin 1-dependent actions of glucocorticoids in the anterior pituitary gland: roles of the N-terminal domain and protein kinase C. Endocrinology. 2002;143(8): 3060-3070.
67. Vergnolle N, et al. Annexin 1 is secreted in situ during ulcerative colitis in humans. Inflamm Bowel Dis. 2004;10(5): 584-592.
68. Wang SB, Hu KM, Seamon KJ, Mani V, Chen Y, Gronert K. Estrogen negatively regulates epithelial wound healing and protective lipid mediator circuits in the cornea. FASEB J. 2012;26(4): 1506-1516.
69. Gronert K, Maheshwari N, Khan N, Hassan IR, Dunn M, Laniado Schwartzman M. A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense. J Biol Chem. 2005;280(15): 15267-15278.
70. Gronert K. Lipoxins in the eye and their role in wound healing. Prostaglandins Leukot Essent Fatty Acids. 2005;73(3-4): 221-229.
71. Shinohara M, et al. Nox1 redox signaling mediates oncogenic Ras-induced disruption of stress fibers and focal adhesions by down-regulating Rho. J Biol Chem. 2007;282(24): 17640-17648.
72. Ostman A, Frijhoff J, Sandin A, Bohmer FD. Regulation of protein tyrosine phosphatases by reversible oxidation. J Biochem. 2011;150(4): 345-356.
73. Chiarugi P, et al. Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion. J Cell Biol. 2003;161(5): 933-944.
74. Chatterjee BE, et al. Annexin 1-deficient neutrophils exhibit enhanced transmigration in vivo and increased responsiveness in vitro. J Leukoc Biol. 2005;78(3): 639-646.
75. Solito E, Kamal A, Russo-Marie F, Buckingham JC, Marullo S, Perretti M. A novel calcium-dependent proapoptotic effect of annexin 1 on human neutrophils. FASEB J. 2003;17(11): 1544-1546.
76. Vago JP, et al. Annexin A1 modulates natural and glucocorticoid-induced resolution of inflammation by enhancing neutrophil apoptosis. J Leukoc Biol. 2012;92(2): 249-258.
77. Zhang Z, Huang L, Zhao W, Rigas B. Annexin 1 induced by anti-inflammatory drugs binds to NFkappaB and inhibits its activation: anticancer effects in vitro and in vivo. Cancer Res. 2010;70(6): 2379-2388.
78. Perretti M, Gavins FN. Annexin 1: an endogenous anti-inflammatory protein. News Physiol Sci. 2003; 18: 60-64.
79. Kumar A, et al. Commensal bacteria modulate cullin- dependent signaling via generation of reactive oxygen species. EMBO J. 2007;26(21): 4457-4466.
80. Collier-Hyams LS, Sloane V, Batten BC, Neish AS. Cutting edge: bacterial modulation of epithelial signaling via changes in neddylation of cullin-1. J Immunol. 2005;175(7): 4194-4198.
81. Hannon R, et al. Aberrant inflammation and resistance to glucocorticoids in annexin 1-/- mouse. FASEB J. 2003;17(2): 253-255.
82. Khounlotham M, et al. Compromised intestinal epithelial barrier induces adaptive immune compensation that protects from colitis. Immunity. 2012;37(3): 563-573.
83. Perretti M, Ahluwalia A, Harris JG, Goulding NJ, Flower RJ. Lipocortin-1 fragments inhibit neutrophil accumulation and neutrophil-dependent edema in the mouse. J Immunol. 1993;151(8): 4306-4314.
84. Patel HB, et al. The impact of endogenous annexin A1 on glucocorticoid control of inflammatory arthritis. Ann Rheum Dis. 2012;71(11): 1872-1880.
85. Lisanti MP, Caras IW, Davitz MA, Rodriguez-Boulan E. A glycophospholipid membrane anchor acts as an apical targeting signal in polarized epithelial cells. J Cell Biol. 1989;109(5): 2145-2156.
86. Mandell KJ, Babbin BA, Nusrat A, Parkos CA. Junctional adhesion molecule 1 regulates epithelial cell morphology through effects on beta1 integrins and Rap1 activity. J Biol Chem. 2005;280(12): 11665-11674.
87. Babbin BA, et al. Formyl peptide receptor-1 activation enhances intestinal epithelial cell restitution through phosphatidylinositol 3-kinase-dependent activation of Rac1 and Cdc42. J Immunol. 2007;179(12): 8112-8121.
88. Kundu K, Knight SF, Willett N, Lee S, Taylor WR, Murthy N. Hydrocyanines: a class of fluorescent sensors that can image reactive oxygen species in cell culture, tissue, and in vivo. Angew Chem Int Ed Engl. 2009;48(2): 299-303.
89. Becker C, et al. TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 transsignaling. Immunity. 2004;21(4): 491-501.
90. Becker C, et al. In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy. Gut. 2005;54(7): 950-954.
91. Manieri NA, Drylewicz MR, Miyoshi H, Stappenbeck TS. Igf2bp1 is required for full induction of Ptgs2 mRNA in colonic mesenchymal stem cells in mice. Gastroenterology. 2012;143(1): 110-121.
92. Pickert G, et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med. 2009;206(7): 1465-1472.